A real-world study confirms survival outcomes of atezolizumab plus chemotherapy in extensive-stage small cell lung cancer. Similar survival outcomes of a real-world study of a first-line treatment regimen were demonstrated in the phase 3 IMpower133...
![PW-Circle-Logo-lockup_Horizontal](https://cdn.physiciansweekly.com/wp-content/uploads/2024/02/PW-Circle-Logo-lockup_Horizontal.webp)